Works matching DE "ABACAVIR-lamivudine (Drug)"

Results: 56
    1
    2

    Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 574, doi. 10.1093/jpids/piad082
    By:
    • Chupradit, Suthunya;
    • Wamalwa, Dalton C;
    • Maleche-Obimbo, Elizabeth;
    • Kekitiinwa, Adeodata R;
    • Mwanga-Amumpaire, Juliet;
    • Bukusi, Elizabeth A;
    • Nyandiko, Winstone M;
    • Mbuthia, Joseph K;
    • Swanson, Alistair;
    • Team, DNDi Clinical;
    • Cressey, Tim R;
    • Punyawudho, Baralee;
    • Musiime, Victor
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 12, p. 3323, doi. 10.1093/jac/dkv276
    By:
    • Wan-Lin Yang;
    • Kouyos, Roger D.;
    • Scherrer, Alexandra U.;
    • Böni, Jürg;
    • Shah, Cyril;
    • Yerly, Sabine;
    • Klimkait, Thomas;
    • Aubert, Vincent;
    • Hirzel, Cédric;
    • Battegay, Manuel;
    • Cavassini, Matthias;
    • Bernasconi, Enos;
    • Vernazza, Pietro;
    • Held, Leonhard;
    • Ledergerber, Bruno;
    • Günthard, Huldrych F.
    Publication type:
    Article
    10
    11

    Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3356, doi. 10.1093/jac/dku265
    By:
    • Seang, S.;
    • Fourati, S.;
    • Keita, Y.;
    • Blanc, C.;
    • Tubiana, R.;
    • Schneider, L.;
    • Valantin, M. A.;
    • Caby, F.;
    • Calin, R.;
    • Lambert-Niclot, S.;
    • Marcelin, A.-G.;
    • Calvez, V.;
    • Costagliola, D.;
    • Katlama, C.
    Publication type:
    Article
    12
    13
    14
    15

    Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.

    Published in:
    HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
    By:
    • Ryom, Lene;
    • De Miguel, Rosa;
    • Cotter, Aoife Grace;
    • Podlekareva, Daria;
    • Beguelin, Charles;
    • Waalewijn, Hylke;
    • Arribas, Josè R;
    • Mallon, Patrick W. G.;
    • Marzolini, Catia;
    • Kirk, Ole;
    • Bamford, Alasdair;
    • Rauch, Andri;
    • Molina, Jean Michel;
    • Kowalska, Justyna Dominika;
    • Guaraldi, Giovanni;
    • Winston, Alan;
    • Boesecke, Christoph;
    • Cinque, Paola;
    • Welch, Steven;
    • Collins, Simon
    Publication type:
    Article
    16

    Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir.

    Published in:
    HIV Medicine, 2022, v. 23, n. 4, p. 362, doi. 10.1111/hiv.13215
    By:
    • Campbell, Lucy;
    • Ibrahim, Fowzia;
    • Barbini, Birgit;
    • Samarawickrama, Amanda;
    • Orkin, Chloe;
    • Fox, Julie;
    • Waters, Laura;
    • Gilleece, Yvonne;
    • Tariq, Shema;
    • Post, Frank A.;
    • Post, Frank;
    • Adegbaju, Oluwayomi;
    • Hamzah, Lisa;
    • Bhagwandin, Priya;
    • Canoso, Ana;
    • Kegg, Stephen;
    • Moussaoui, Tarik;
    • Lwanga, Julianne;
    • Sharp, Alice;
    • Aminata, Mohammed
    Publication type:
    Article
    17
    18

    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

    Published in:
    HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
    By:
    • Poveda, E;
    • Hernández‐Quero, J;
    • Pérez‐Elías, MJ;
    • Ribas, MA;
    • Martínez‐Madrid, OJ;
    • Flores, J;
    • Navarro, J;
    • Gutiérrez, F;
    • García‐Deltoro, M;
    • Imaz, A;
    • Ocampo, A;
    • Artero, A;
    • Blanco, F;
    • Bernal, E;
    • Pasquau, J;
    • Mínguez‐Gallego, C;
    • Pérez, N;
    • Aiestaran, A;
    • García, F;
    • Paredes, R
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 12, p. 2112, doi. 10.1093/cid/cix734
    By:
    • Pulido, Federico;
    • Ribera, Esteban;
    • Lagarde, María;
    • Pérez-Valero, Ignacio;
    • Palacios, Rosario;
    • Iribarren, José A.;
    • Payeras, Antoni;
    • Domingo, Pere;
    • Sanz, José;
    • Cervero, Miguel;
    • Curran, Adrián;
    • Rodríguez-Gómez, Francisco J.;
    • Téllez, María J.;
    • Ryan, Pablo;
    • Barrufet, Pilar;
    • Knobel, Hernando;
    • Rivero, Antonio;
    • Alejos, Belén;
    • Yllescas, María;
    • Arribas, José R.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Published in:
    2017
    By:
    • Troya, Jesús;
    • Ryan, Pablo;
    • Ribera, Esteban;
    • Podzamczer, Daniel;
    • Hontañón, Victor;
    • Terrón, Jose Alberto;
    • Boix, Vicente;
    • Moreno, Santiago;
    • Barrufet, Pilar;
    • Castaño, Manuel;
    • Carrero, Ana;
    • Galindo, María José;
    • Suárez-Lozano, Ignacio;
    • Knobel, Hernando;
    • Raffo, Miguel;
    • Solís, Javier;
    • Yllescas, María;
    • Esteban, Herminia;
    • González-García, Juan;
    • Berenguer, Juan
    Publication type:
    Correction Notice
    45
    46
    47
    48
    49
    50